Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Teligent Pharma, Inc.
FDA Inspection
•Teligent Pharma, Inc.•May 20, 2019

Teligent Pharma, Inc. – FDA Inspection, May 20, 2019

Record Details

This FDA Inspection record concerns Teligent Pharma, Inc., with an inspection on May 20, 2019, issued by the New Jersey District Office, covering human drugs.

Company
Teligent Pharma, Inc.
Inspection Date
May 20, 2019
Product Type
Human Drugs
Office
New Jersey District Office
Person
  • Nancy M. Espinal (FDA Associated Person)
View Company Profile

ID · 67eb4a19-49ae-4c3f-97a1-43cc71400846

Inspection Facts

Inspection number
1090090
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.165(f)Failing drug products not rejected
  3. 21 CFR 211.166(a)Written program not followed
  4. 21 CFR 211.180(c)Records not made readily available to FDA
  5. 21 CFR 211.180(e)(1)Review of representative number of batches
  6. 21 CFR 211.192Extent of discrepancy, failure investigations
  7. 21 CFR 211.192No written record of investigation
  8. 21 CFR 211.194(a)(6)Comparison of Test Results to Specifications
  9. 21 CFR 211.198(a)Procedures to be written and followed
  10. 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Teligent Pharma, Inc.

8
DateClassificationOfficeProject area
August 31, 2021OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 19, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 22, 2016NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
December 19, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 2, 2012NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Teligent Pharma, Inc.
  • FDA Inspection 1150271 - 2021-08-31
  • FDA Inspection 1032023 - 2017-10-19
  • FDA Inspection 956413 - 2016-01-22
  • FDA Inspection 859472 - 2013-12-19
  • FDA Inspection 765396 - 2012-02-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teligent Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.